TY - JOUR
T1 - Behavioral and psychological symptoms of dementia and Alzheimer’s disease progression in Down syndrome
AU - the Alzheimer Biomarker Consortium - Down syndrome
AU - Jenkins, Melissa R.
AU - Peven, Jamie C.
AU - Kubic, Lauren
AU - Handen, Benjamin L.
AU - Krinsky-McHale, Sharon J.
AU - Hom, Christy L.
AU - Lee, Alice
AU - Tudorascu, Dana L.
AU - McLachlan, Max
AU - Zammit, Matthew
AU - Minhas, Davneet
AU - Luo, Weiquan
AU - Laymon, Charles
AU - Lee, Joseph H.
AU - Lott, Ira
AU - Cohen, Annie
AU - Ances, Beau M.
AU - Rosas, H. Diana
AU - Lai, Florence
AU - Zaman, Shahid H.
AU - Head, Elizabeth
AU - Mapstone, Mark
AU - Christian, Bradley T.
AU - Hartley, Sigan L.
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - Background: Adults with Down syndrome (DS) have a 90% lifetime risk for Alzheimer’s disease (AD), with neurobiological pathology present decades prior to dementia onset. The profile and timing of cognitive decline in DS is well-documented. However, there is a small body of research on whether Behavioral and Psychological Symptoms of Dementia (BPSD) occur early on in the progression of AD in DS and are associated with early AD pathology (i.e., amyloid-beta [Aβ] and neurofibrillary tau tangles [NFT]). Methods: Data were analyzed from 337 adults with DS (M = 45.13 years, SD = 9.53 years) enrolled in a large cohort study. The Reiss Screen for Maladaptive Behavior (RSMB) measured common behaviors reported in BPSD across up to four study cycles (spaced approximately 16 months apart). Linear mixed models estimated change in BPSD as predicted by baseline (a) dementia status (i.e., cognitively stable, mild cognitive impairment [MCI], or dementia), (b) Aβ positron emission tomography (PET) tracer [11C] PiB, and (c) NFT PET tracer [18F]AV-1451. Models controlled for chronological age, sex, study site, premorbid intellectual disability level, APOE e4 allele carrier status, psychiatric diagnoses, and psychiatric medication use. Results: Compared to cognitively stable participants, participants whose status was MCI or dementia, had significantly higher baseline RSMB subdomain scores. Increases in RSMB Depression-Behavioral, Depression-Physical, and Psychosis were observed for participants with MCI. Higher baseline Aβ and NFT were associated with higher RSMB Avoidant at baseline, and increases in RSMB Depression-Physical and Psychosis over time. Conclusions: BPSD are an important part of AD in DS, particularly during the prodromal stage. Elevated Aβ and NFT predict higher initial avoidance and change in physical depression behaviors and may indicate MCI in adults with DS. Broader increases in BPSD are observed as adults with DS progress from early to late-stage dementia. Clinicians should rule out other possible causes of BPSD when screening for AD, such as stressful life experiences or co-occurring medical conditions. Caregivers of adults with DS should have resources on BPSD management and self-care strategies.
AB - Background: Adults with Down syndrome (DS) have a 90% lifetime risk for Alzheimer’s disease (AD), with neurobiological pathology present decades prior to dementia onset. The profile and timing of cognitive decline in DS is well-documented. However, there is a small body of research on whether Behavioral and Psychological Symptoms of Dementia (BPSD) occur early on in the progression of AD in DS and are associated with early AD pathology (i.e., amyloid-beta [Aβ] and neurofibrillary tau tangles [NFT]). Methods: Data were analyzed from 337 adults with DS (M = 45.13 years, SD = 9.53 years) enrolled in a large cohort study. The Reiss Screen for Maladaptive Behavior (RSMB) measured common behaviors reported in BPSD across up to four study cycles (spaced approximately 16 months apart). Linear mixed models estimated change in BPSD as predicted by baseline (a) dementia status (i.e., cognitively stable, mild cognitive impairment [MCI], or dementia), (b) Aβ positron emission tomography (PET) tracer [11C] PiB, and (c) NFT PET tracer [18F]AV-1451. Models controlled for chronological age, sex, study site, premorbid intellectual disability level, APOE e4 allele carrier status, psychiatric diagnoses, and psychiatric medication use. Results: Compared to cognitively stable participants, participants whose status was MCI or dementia, had significantly higher baseline RSMB subdomain scores. Increases in RSMB Depression-Behavioral, Depression-Physical, and Psychosis were observed for participants with MCI. Higher baseline Aβ and NFT were associated with higher RSMB Avoidant at baseline, and increases in RSMB Depression-Physical and Psychosis over time. Conclusions: BPSD are an important part of AD in DS, particularly during the prodromal stage. Elevated Aβ and NFT predict higher initial avoidance and change in physical depression behaviors and may indicate MCI in adults with DS. Broader increases in BPSD are observed as adults with DS progress from early to late-stage dementia. Clinicians should rule out other possible causes of BPSD when screening for AD, such as stressful life experiences or co-occurring medical conditions. Caregivers of adults with DS should have resources on BPSD management and self-care strategies.
KW - Alzheimer’s disease
KW - Amyloid
KW - Down syndrome
KW - Psychiatric symptoms
KW - Tau
UR - http://www.scopus.com/inward/record.url?scp=105003323852&partnerID=8YFLogxK
U2 - 10.1186/s11689-025-09604-w
DO - 10.1186/s11689-025-09604-w
M3 - Article
C2 - 40217501
AN - SCOPUS:105003323852
SN - 1866-1947
VL - 17
JO - Journal of neurodevelopmental disorders
JF - Journal of neurodevelopmental disorders
IS - 1
M1 - 19
ER -